Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 4/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14028611 | 0.92 | PRKCA (0.44) | PRKCAMAPTMMP8ELANEPRKCD | |
| SCHEMBL13168170 | 0.89 | PRKCA (0.55) | PRKCAMAPTMMP8ELANEPRKCD | |
| SCHEMBL23293585 | 0.85 | MAPT (0.43) | PRKCAMAPTMMP8FFAR1CA1 | |
| SCHEMBL30358371 | 0.84 | PRKCA (0.52) | PRKCAMAPTMMP8ELANEPRKCD | |
| SCHEMBL19452281 | 0.83 | MAPT (0.46) | PRKCAMAPTMMP8ELANEFFAR1 | |
| SCHEMBL20747627 | 0.83 | MAPT (0.42) | PRKCAMAPTMMP8FFAR1 | |
| SCHEMBL18856339 | 0.83 | MAPT (0.42) | PRKCAMAPTMMP8FFAR1 | |
| SCHEMBL8988305 | 0.83 | MAPT (0.42) | PRKCAMAPTMMP8CYP4F2CYP4A11 | |
| SCHEMBL18388276 | 0.83 | PRKCA (0.47) | PRKCAMAPTMMP8PRKCDPOLB | |
| SCHEMBL13168165 | 0.81 | PRKCA (0.48) | PRKCAMMP8PRKCDPOLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109119598-B | Non-aqueous electrolyte and secondary battery | 微宏动力系统（湖州）有限公司 | 2021-09-21 | — | — | CN | claimed |
| CN-113871683-B | Method for improving high-temperature performance of non-aqueous electrolyte battery | 宁波梅山保税港区锂泰企业管理合伙企业(有限合伙) | 2022-06-17 | — | — | CN | disclosed |
| CN-114614018-A | Lithium ion battery negative electrode material, preparation method thereof and lithium ion secondary battery | 宁波梅山保税港区锂泰企业管理合伙企业(有限合伙) | 2022-06-10 | — | — | CN | disclosed |
| CN-113871683-A | Method for improving high-temperature performance of non-aqueous electrolyte battery | 宁波行殊新能源科技有限公司 | 2021-12-31 | — | — | CN | disclosed |
| CN-109119598-B | Non-aqueous electrolyte and secondary battery | 微宏动力系统（湖州）有限公司 | 2021-09-21 | — | — | CN | disclosed |
| CN-107666011-B | Non-aqueous electrolyte and non-aqueous electrolyte secondary battery | 微宏动力系统（湖州）有限公司 | 2020-07-28 | — | — | CN | disclosed |
| EP-3383494-A1 | HISTONE DEACETYLASE INHIBITORS | The Regents of The University of California (US) | 2018-10-10 | — | — | EP | disclosed |
| WO-2017096298-A1 | HISTONE DEACETYLASE INHIBITORS | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-06-08 | — | — | WO | disclosed |
| US-20120014975-A1 | MODIFIED SINGLE DOMAIN ANTIGEN BINDING MOLECULES AND USES THEREOF | WYETH LLC (US) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120014975-A1 | MODIFIED SINGLE DOMAIN ANTIGEN BINDING MOLECULES AND USES THEREOF | TNFSF11, CD40, CD2BP2 | PRKCA 1547/4885MAPT 3444/4885MMP8 1618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.